CCI vs FDMT · P/E 40, rev $6.57B vs rev $37.0K
Crown Castle (CCI) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the CCI and FDMT stock pages for the full models.
Not investment advice.